Skip to main content
KURA logo
KURA
(NASDAQ)
Kura Oncology, Inc.
$9.05-- (--)
Loading... - Market loading

Kura Oncology (KURA) Stock Price & Financial Analysis

Kura Oncology Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$8.84 - $9.21
52-Week High$12.49
52-Week Low$5.45
Open$8.85
Volume1.29M
Average Volume (3M)1.94M
Market Cap761.03M
Shares Outstanding87.68M
Price to Sales (P/S)11.28
Price to Book (P/B)4.37
EV/EBITDA-2.19
Revenue (TTM)67.48M
Net Income (TTM)-278.67M
Free Cash Flow (TTM)-70.70M
EPS (TTM)$-3.18
Profit Margin-412.95%
Operating Margin-449.94%
Return on Equity (ROE)-160.03%
Debt to Equity0.12
50-Day MA$9.26
200-Day MA$9.33
52-Week Change28.03%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Kura Oncology

What is the current stock price for KURA?

As of the latest trading session, KURA stock trades at $9.05. The 52-week range is $5.45–$12.49, with a day range of $8.84–$9.21.

What is the P/E ratio for KURA?

The P/E ratio (Price-to-Earnings) for KURA is shown in the Key Statistics section. This valuation metric helps compare Kura Oncology, Inc. to industry peers.

Does KURA pay dividends?

Kura Oncology does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for KURA?

Based on 2 analysts, the consensus for KURA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of KURA?

Kura Oncology's market capitalization is $793.5M, classifying it as a small-cap company. Kura Oncology operates in the Healthcare sector within the Biotechnology industry.